Ayuray Organics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-01-2025
- Paid Up Capital ₹ 2.50 M
as on 08-01-2025
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 08-01-2025
- Revenue 303.19%
(FY 2022)
- Profit -23.29%
(FY 2022)
- Ebitda -21.79%
(FY 2022)
- Net Worth -391.58%
(FY 2022)
- Total Assets 25.55%
(FY 2022)
About Ayuray Organics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Tarsem Ruby and Shivansh Sharma serve as directors at the Company.
- CIN/LLPIN
U74999CH2020PTC043070
- Company No.
043070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ayuray Organics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivansh Sharma  | Director | 08-Jul-2020 | Current |
| Tarsem Ruby | Director | 08-Jul-2020 | Current |
Financial Performance of Ayuray Organics.
Ayuray Organics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 303.19% increase. The company also saw a substantial fall in profitability, with a 23.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 391.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayuray Organics?
Unlock access to Ayuray Organics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Raymed Pharmaceuticals LimitedActive 30 years 7 daysTarsem Ruby and Shivansh Sharma are mutual person
Raymed Ophthalmic Private LimitedActive 5 years 8 monthsTarsem Ruby and Shivansh Sharma are mutual person
- Raymzon Trade Links Private LimitedActive 4 years 5 months
Tarsem Ruby and Shivansh Sharma are mutual person
- Aquavision Pharmaceuticals Private LimitedActive 4 years 3 months
Tarsem Ruby and Shivansh Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Mar 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Ayuray Organics?
Unlock and access historical data on people associated with Ayuray Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayuray Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayuray Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
